Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Arwa oil promotes healthy hair growth and has antimicrobial benefits.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Abatacept may help some people with alopecia areata regrow hair.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

New treatments for alopecia areata show promise, but their real-world effectiveness and impact on life and sexual health need more study.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

New drug uses show promise but need more research.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Upadacitinib effectively treats psoriasis and lichen planus together.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The hydrogel with neem and tridax extracts effectively treats seborrheic dermatitis.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.